Skip to main content
SpringerLink
Log in

Declaration of Fructose and Fructose-Related Adverse Effects in Commercial Drug Preparations in European Countries

  • Correspondence
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Notes

  1. Use of tradenames is for product identification only and does not imply endorsement.

References

  1. Ginther B. Hereditary fructose intolerance [online]. Available from URL: http://www.mssc.edu/biology/B305/GTS/ws00/heredity/disease/disease.htm [Accessed 2003 May 22]

  2. Locher S. Acute liver and kidney failure following sorbitol infusion in a 28-year-old patient with undiagnosed fructose intolerance. Anasth Intensivther Notfallmed 1987; 22: 194–7

    Article  PubMed  CAS  Google Scholar 

  3. Rey M, Begrens R, Zeilinger G. Fatal consequences of fructose infusion in undiagnosed fructose intolerance. Dtsch Med Wochenschr 1988; 113: 945–7

    Article  PubMed  CAS  Google Scholar 

  4. Breckenridge AM, Kendall M, Raine JM, editors. Reminder - fructose and sorbitol containing parenteral solutions should not be used. Medicines Control Agency and Committee on Safety of Medicines. Curr Probl Pharmacovigilance 2001; 27: 12

    Google Scholar 

  5. European Commission. Excipients in the label and package leaflet of medicinal products for human use [online]. Available from URL: http://pharmacos.eudra.org/F2/eudralex/vol-3/pdfs-en/3bc7aen.pdf [Accessed 2003 May 22]

  6. Felleskatalogen AS, Oslo: Felleskatalogen [online]. Available from URL: http://www.felleskatalogen.no [Accessed 2003 May 22]

  7. Läkemiddelindustriföreningen (LIF), Stockholm: Farmaceutiska specialiteter i Sverige (FASS) [online]. Available from URL: http://www.fass.se [Accessed 2003 May 22]

  8. Rote Liste Service GmbH, Frankfurt: Rote Liste [online]. Available from URL: http://www.rote-liste.de [Accessed 2003 May 22]

  9. Association of the British Pharmaceutical Industry: electronic Medicines Compendium (eMC) [online]. Available from URL: http://www.emc.vhn.net/professional [Accessed 2003 May 22]

  10. Doose DR, Streeter AJ. Topiramate: chemistry, biotransformation, and pharmacokinetics. In: Levy RH, Mattson RH, Meldrum BS, et al., editors. Antiepileptic drugs. Philadelphia: Lippincott Williams & Wilkins, 2003: 727–734

    Google Scholar 

  11. Bjoro K, Gjerstad L, Bentdal O, et al. Topiramate and fulminant liver failure. Lancet 1998; 352(9134): 1119

    PubMed  CAS  Google Scholar 

  12. Doan RJ, Clendenning M. Topiramate and hepatotoxicity. Can J Psychiatry 2000; 45(10): 937–8

    PubMed  CAS  Google Scholar 

  13. Longin E, Teich M, Koelfen W, et al. Topiramate enhances the risk for valproate-associated side effects in three children. Epilepsia 2002; 43(3): 451–454

    Article  PubMed  Google Scholar 

  14. Pellock JM, Thienel U, Wang S, et al. Hepatic injury in topiramate-treated patients: a comprehensive review of the worldwide safety database [abstract no. P04.009]. Proceedings of the American Academy of Neurology 54th Annual Meeting; 2002 Apr 13-20; Denver (CO)

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, St Olav Hospital, Olav Kyrres gt. 17, Trondheim, 7006, Norway

    Arne Reimers & Olav Spigset

Authors
  1. Arne Reimers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Olav Spigset
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reimers, A., Spigset, O. Declaration of Fructose and Fructose-Related Adverse Effects in Commercial Drug Preparations in European Countries. Drug-Safety 26, 1057–1059 (2003). https://doi.org/10.2165/00002018-200326140-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200326140-00006

Keywords

Search

Navigation